Sanofi (SNY) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SNY Stock Alerts $49.03 +1.20 (+2.51%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 10:51 AM | marketbeat.comManhattan West Asset Management LLC Boosts Stake in Sanofi (NASDAQ:SNY)Manhattan West Asset Management LLC raised its position in Sanofi (NASDAQ:SNY - Free Report) by 57.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 67,928 shares of the company's stock after buying an additional 24,817 shares during the periMay 31 at 6:00 AM | globenewswire.comPress Release: Sanofi launches 2024 global Employee Stock Purchase PlanMay 31 at 1:31 AM | reuters.comFDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'May 31 at 1:05 AM | globenewswire.comPress Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDMay 31 at 1:00 AM | globenewswire.comPress Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammationMay 30 at 9:01 AM | globenewswire.comPress Release: Sanofi completes acquisition of Inhibrx, Inc.May 30 at 6:42 AM | americanbankingnews.comSanofi (NASDAQ:SNY) Short Interest Down 26.8% in MayMay 30 at 5:42 AM | americanbankingnews.comQ2 2024 EPS Estimates for Sanofi Cut by Analyst (NASDAQ:SNY)May 29 at 7:28 AM | marketbeat.comUS Bancorp DE Has $4.34 Million Position in Sanofi (NASDAQ:SNY)US Bancorp DE lowered its stake in Sanofi (NASDAQ:SNY - Free Report) by 28.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,338 shares of the company's stock after selling 33,953 shares during the quarMay 28, 2024 | finance.yahoo.comFDA accepts Sanofi’s Sarclisa sBLA for priority reviewMay 27, 2024 | marketbeat.comCORDA Investment Management LLC. Sells 23,015 Shares of Sanofi (NASDAQ:SNY)CORDA Investment Management LLC. reduced its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 14.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,018 shares of the cMay 27, 2024 | finanznachrichten.deSanofi: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaMay 27, 2024 | globenewswire.comPress Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaMay 26, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Holdings Raised by Corient Private Wealth LLCCorient Private Wealth LLC raised its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 62.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 169,494 shares of the company's stock after buying an additional 64,949 shMay 25, 2024 | marketbeat.comPNC Financial Services Group Inc. Has $5 Million Stake in Sanofi (NASDAQ:SNY)PNC Financial Services Group Inc. lessened its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 48.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 100,496 shares of the companMay 23, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by Wells Fargo & Company MNWells Fargo & Company MN cut its stake in Sanofi (NASDAQ:SNY - Free Report) by 9.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,255,360 shares of the company's stock after selling 238,228 shares during theMay 22, 2024 | msn.comBristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900MMay 22, 2024 | marketbeat.comJPL Wealth Management LLC Takes $955,000 Position in Sanofi (NASDAQ:SNY)JPL Wealth Management LLC acquired a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 19,209 shares of the company's stock, valued at approximately $955,000. Several other institMay 22, 2024 | benzinga.comFirst Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows PotentialMay 22, 2024 | benzinga.comHawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916MMay 22, 2024 | reuters.comBristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 millionMay 21, 2024 | msn.comNovavax top investor ends proxy fight after Sanofi dealMay 21, 2024 | benzinga.comChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug DevelopmentMay 21, 2024 | msn.comSanofi teams up with Formation Bio, OpenAI on AI-driven drug developmentMay 21, 2024 | marketwatch.comFrance's Sanofi partners with OpenAI to accelerate drug developmentMay 21, 2024 | investing.comSanofi partners with OpenAI, Formation Bio on AI-driven drug developmentMay 21, 2024 | reuters.comSanofi partners with OpenAI, Formation Bio on AI-driven drug developmentMay 21, 2024 | globenewswire.comPress Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaborationMay 20, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Bought by Brandes Investment Partners LPBrandes Investment Partners LP raised its holdings in Sanofi (NASDAQ:SNY - Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,770,572 shares of the companMay 20, 2024 | globenewswire.comPress Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMMay 20, 2024 | reuters.comShah Capital ends campaign against Novavax board after Sanofi dealMay 19, 2024 | marketbeat.comAMG National Trust Bank Decreases Position in Sanofi (NASDAQ:SNY)AMG National Trust Bank lowered its stake in Sanofi (NASDAQ:SNY - Free Report) by 54.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 30,428 shares of the company's stock after selling 36,532 shares during the quarter. AMG National Trust Bank's holdings inMay 18, 2024 | marketbeat.comJanney Montgomery Scott LLC Buys 141,889 Shares of Sanofi (NASDAQ:SNY)Janney Montgomery Scott LLC boosted its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 103.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 278,545 shares of the company's stock after bMay 17, 2024 | marketbeat.comOxbow Advisors LLC Acquires New Holdings in Sanofi (NASDAQ:SNY)Oxbow Advisors LLC acquired a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 94,294 shares of the company's stock, valuMay 16, 2024 | benzinga.comPfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma GameMay 14, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Gap Down to $50.21Sanofi (NASDAQ:SNY) Shares Gap Down to $50.21May 13, 2024 | msn.comNovavax (NASDAQ:NVAX) Explodes 50% Higher after Sanofi DealMay 13, 2024 | markets.businessinsider.comBuy Rating Upheld for Fulcrum Therapeutics Amid Sanofi Partnership and Upcoming Trial CatalystsMay 13, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Hold Rating on Sanofi (SNY)May 13, 2024 | cnbc.comNovavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine makerMay 13, 2024 | markets.businessinsider.comFulcrum Therapeutics Stock Climbs In Pre-market On License Deal With Sanofi For LosmapimodMay 13, 2024 | marketwatch.comSanofi to spend $1.08 billion on ramping up French production capabilitiesMay 13, 2024 | msn.comSanofi to invest over €1 billion in French production sitesMay 13, 2024 | markets.businessinsider.comSanofi To Invest Over EUR 1 Bln Further For Biomanufacturing In FranceMay 13, 2024 | reuters.comSanofi pledges new 1 bln euros worth of investments in French production sitesMay 13, 2024 | globenewswire.comPress Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyMay 12, 2024 | marketbeat.comBoston Partners Has $648.62 Million Holdings in Sanofi (NASDAQ:SNY)Boston Partners grew its position in Sanofi (NASDAQ:SNY - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,032,746 shares of the company's stock after buying an additional 245,68May 11, 2024 | marketbeat.comShort Interest in Sanofi (NASDAQ:SNY) Increases By 67.9%Sanofi (NASDAQ:SNY - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 5,440,000 shares, a growth of 67.9% from the April 15th total of 3,240,000 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily trading volume, of 2,030,000 shares, the short-interest ratio is presently 2.7 days.May 11, 2024 | marketbeat.comPrincipal Securities Inc. Takes Position in Sanofi (NASDAQ:SNY)Principal Securities Inc. bought a new stake in Sanofi (NASDAQ:SNY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 35,363 shares of the company's stock, valued at approximately $1,759,000. A number of other hedge fuMay 10, 2024 | theglobeandmail.comNovavax shares soar on license deal with Sanofi at lofty valuation Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… SNY Media Mentions By Week SNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.600.78▲Average Medical News Sentiment SNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼199▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BIIB News JNJ News MRK News ABBV News AZN News NVS News ABT News PFE News VRTX News REGN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
